138 related articles for article (PubMed ID: 21972004)
1. SNP rs2470152 in CYP19 is correlated to aromatase activity in Chinese polycystic ovary syndrome patients.
Zhang XL; Zhang CW; Xu P; Liang FJ; Che YN; Xia YJ; Cao YX; Wu XK; Wang WJ; Yi L; Gao Q; Wang Y
Mol Med Rep; 2012 Jan; 5(1):245-9. PubMed ID: 21972004
[TBL] [Abstract][Full Text] [Related]
2. Association between CYP19 gene SNP rs2414096 polymorphism and polycystic ovary syndrome in Chinese women.
Jin JL; Sun J; Ge HJ; Cao YX; Wu XK; Liang FJ; Sun HX; Ke L; Yi L; Wu ZW; Wang Y
BMC Med Genet; 2009 Dec; 10():139. PubMed ID: 20015405
[TBL] [Abstract][Full Text] [Related]
3. Impact of rs2414096 polymorphism of CYP19 gene on susceptibility of polycystic ovary syndrome and hyperandrogenism in Kashmiri women.
Ashraf S; Rasool SUA; Nabi M; Ganie MA; Masoodi SR; Amin S
Sci Rep; 2021 Jun; 11(1):12942. PubMed ID: 34155264
[TBL] [Abstract][Full Text] [Related]
4. The synergistic effect of sex hormone-binding globulin and aromatase genes on polycystic ovary syndrome phenotype.
Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
Eur J Endocrinol; 2008 Jun; 158(6):861-5. PubMed ID: 18505907
[TBL] [Abstract][Full Text] [Related]
5. Association of the
Munawar Lone N; Babar S; Sultan S; Malik S; Nazeer K; Riaz S
Gynecol Endocrinol; 2021 May; 37(5):456-461. PubMed ID: 32960117
[TBL] [Abstract][Full Text] [Related]
6. The (TTTA)n polymorphism in intron 4 of CYP19 and the polycystic ovary syndrome risk in a Chinese population.
Xu P; Zhang XL; Xie GB; Zhang CW; Shen SM; Zhang XX; Cao YX; Wang WJ; Che YN; Xia YJ; Wu XK; Yi L; Gao Q; Wang Y
Mol Biol Rep; 2013 Aug; 40(8):5041-7. PubMed ID: 23661022
[TBL] [Abstract][Full Text] [Related]
7. Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism.
Gharani N; Waterworth DM; Batty S; White D; Gilling-Smith C; Conway GS; McCarthy M; Franks S; Williamson R
Hum Mol Genet; 1997 Mar; 6(3):397-402. PubMed ID: 9147642
[TBL] [Abstract][Full Text] [Related]
8. Association of CYP17A1 gene -34T/C polymorphism with polycystic ovary syndrome in Han Chinese population.
Li L; Gu ZP; Bo QM; Wang D; Yang XS; Cai GH
Gynecol Endocrinol; 2015 Jan; 31(1):40-3. PubMed ID: 25208301
[TBL] [Abstract][Full Text] [Related]
9. Association between polymorphisms of the CYP11A1 gene and polycystic ovary syndrome in Chinese women.
Zhang CW; Zhang XL; Xia YJ; Cao YX; Wang WJ; Xu P; Che YN; Wu XK; Yi L; Gao Q; Wang Y
Mol Biol Rep; 2012 Aug; 39(8):8379-85. PubMed ID: 22699877
[TBL] [Abstract][Full Text] [Related]
10. Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.
Maier PS; Spritzer PM
Gynecol Obstet Invest; 2012; 74(2):136-42. PubMed ID: 22889864
[TBL] [Abstract][Full Text] [Related]
11. The relationship between the CYP19 alleles rs727479A/C, rs700518A/G, and rs700519C/T and pregnancy outcome after assisted reproductive technology in patients with polycystic ovary syndrome in a Chinese population: A population-based study.
Dou Q; Tan L; Ma LY; Sun YP
Kaohsiung J Med Sci; 2017 Nov; 33(11):558-566. PubMed ID: 29050673
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the association between the CYP19 Tetranucleotide (TTTA)n polymorphism and polycystic ovarian syndrome(PCOS) in Han Chinese women.
Hao CF; Zhang N; Qu Q; Wang X; Gu HF; Chen ZJ
Neuro Endocrinol Lett; 2010; 31(3):370-4. PubMed ID: 20588246
[TBL] [Abstract][Full Text] [Related]
13. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls.
Sun J; Fan H; Che Y; Cao Y; Wu X; Sun HX; Liang F; Yi L; Wang Y
BMC Med Genet; 2009 Jul; 10():64. PubMed ID: 19602270
[TBL] [Abstract][Full Text] [Related]
14. CYP19 gene: a genetic modifier of polycystic ovary syndrome phenotype.
Xita N; Lazaros L; Georgiou I; Tsatsoulis A
Fertil Steril; 2010 Jun; 94(1):250-4. PubMed ID: 19324338
[TBL] [Abstract][Full Text] [Related]
15. Effects of apoC1 genotypes on the hormonal levels, metabolic profile and PAF-AH activity in Chinese women with polycystic ovary syndrome.
Zhang R; Liu Q; Liu H; Bai H; Zhang Y; Guan L; Fan P
Lipids Health Dis; 2018 Apr; 17(1):77. PubMed ID: 29636060
[TBL] [Abstract][Full Text] [Related]
16. Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome.
Hegde P; Shetty SS; Shetty PK; Manjeera L; Shetty DP; Kumari S
J Genet Eng Biotechnol; 2023 Aug; 21(1):87. PubMed ID: 37603197
[TBL] [Abstract][Full Text] [Related]
17. Association of aromatase (CYP 19) gene variation with features of hyperandrogenism in two populations of young women.
Petry CJ; Ong KK; Michelmore KF; Artigas S; Wingate DL; Balen AH; de Zegher F; Ibáñez L; Dunger DB
Hum Reprod; 2005 Jul; 20(7):1837-43. PubMed ID: 15802318
[TBL] [Abstract][Full Text] [Related]
18. Association Study between Polycystic Ovarian Syndrome and the Susceptibility Genes Polymorphisms in Hui Chinese Women.
Ha L; Shi Y; Zhao J; Li T; Chen ZJ
PLoS One; 2015; 10(5):e0126505. PubMed ID: 25978310
[TBL] [Abstract][Full Text] [Related]
19. CYP19 gene expression in subcutaneous adipose tissue is associated with blood pressure in women with polycystic ovary syndrome.
Lecke SB; Morsch DM; Spritzer PM
Steroids; 2011 Nov; 76(12):1383-8. PubMed ID: 21807013
[TBL] [Abstract][Full Text] [Related]
20. Association of SOD2 A16V and PON2 S311C polymorphisms with polycystic ovary syndrome in Chinese women.
Liu Q; Liu H; Bai H; Huang W; Zhang R; Tan J; Guan L; Fan P
J Endocrinol Invest; 2019 Aug; 42(8):909-921. PubMed ID: 30607774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
